Zacks Investment Research upgraded shares of HealthStream (NASDAQ:HSTM) from a hold rating to a buy rating in a report published on Wednesday. They currently have $32.00 price target on the technology company’s stock.
According to Zacks, “HealthStream’s suite of solutions is contracted by healthcare employees in the U.S. for workforce development, training & learning management, talent management, credentialing, privileging, provider enrollment, performance assessment, and managing simulation-based education programs. Based in Nashville, Tennessee, HealthStream has additional offices in Brentwood, Tennessee; Jericho, New York; Boulder, Colorado; Chicago, Illinois and San Diego, California. “
Several other research analysts have also recently issued reports on HSTM. Barrington Research restated a hold rating on shares of HealthStream in a report on Wednesday, July 25th. ValuEngine upgraded shares of HealthStream from a hold rating to a buy rating in a report on Tuesday, July 10th. BidaskClub upgraded shares of HealthStream from a sell rating to a hold rating in a report on Friday, August 3rd. Canaccord Genuity restated a hold rating and issued a $26.00 target price on shares of HealthStream in a report on Monday, July 23rd. Finally, Cantor Fitzgerald restated a hold rating and issued a $25.00 target price on shares of HealthStream in a report on Monday, July 23rd. Seven research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of $27.40.
HealthStream (NASDAQ:HSTM) last issued its earnings results on Monday, October 22nd. The technology company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.03. HealthStream had a net margin of 14.23% and a return on equity of 4.00%. The business had revenue of $59.93 million during the quarter, compared to analysts’ expectations of $58.22 million. During the same quarter in the prior year, the business posted $0.08 EPS. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. Sell-side analysts predict that HealthStream will post 0.38 earnings per share for the current year.
Several institutional investors have recently modified their holdings of HSTM. Royal Bank of Canada raised its position in HealthStream by 10.6% in the 1st quarter. Royal Bank of Canada now owns 27,807 shares of the technology company’s stock valued at $691,000 after purchasing an additional 2,663 shares during the last quarter. Macquarie Group Ltd. purchased a new stake in HealthStream in the 2nd quarter valued at $322,000. Renaissance Technologies LLC raised its position in HealthStream by 379.2% in the 2nd quarter. Renaissance Technologies LLC now owns 306,200 shares of the technology company’s stock valued at $8,362,000 after purchasing an additional 242,300 shares during the last quarter. Principal Financial Group Inc. raised its position in HealthStream by 2.9% in the 1st quarter. Principal Financial Group Inc. now owns 196,466 shares of the technology company’s stock valued at $4,878,000 after purchasing an additional 5,524 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in HealthStream by 3.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,508,142 shares of the technology company’s stock valued at $41,187,000 after purchasing an additional 54,836 shares during the last quarter. Institutional investors and hedge funds own 71.99% of the company’s stock.
HealthStream Company Profile
HealthStream, Inc provides workforce and provider solutions to the healthcare organizations in the United States. It operates in HealthStream Workforce Solutions and HealthStream Provider Solutions segments. The company offers workforce development solutions comprising software-as-a-service (SaaS) and subscription-based products to meet talent management, training, certification, competency assessment, performance appraisal, and development needs, as well as training, implementation, and account management services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.